Research

Hormonal

Phase 2 trials of retatrutide revealed weight reductions approaching 24.2% over 48 weeks.

Retatrutide may offer substantial weight loss benefits for individuals with obesity over a 48-week period.

StrongSupportsmedium confidence
Phase 2 trials of retatrutide revealed even more remarkable outcomes, with weight reductions approaching 24.2% over 48 weeks.
Rafał Bednarczyk et al. · International Journal of Innovative Technologies in Social Science · 2026

Why this rating

Based on the mention of phase 2 clinical trials.

Source

TIRZEPATIDE AND RETATRUTIDE IN THE TREATMENT OF OBESITY AND TYPE 2 DIABETES MELLITUS: CURRENT EVIDENCE AND FUTURE DIRECTIONS. A SYSTEMATIC REVIEW OF CURRENT LITERATURE

Rafał Bednarczyk et al. · International Journal of Innovative Technologies in Social Science · 2026

DOI 10.31435/ijitss.1(49).2026.4671

systematic_review
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →